Zymeworks (ZYME) Misses Q3 EPS by 26c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts ZYME Hot Sheet
Join SI Premium – FREE
Zymeworks (NASDAQ: ZYME) reported Q3 EPS of ($0.26). Revenue for the quarter came in at $27.6 million.
For earnings history and earnings-related data on Zymeworks (ZYME) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Zymeworks (ZYME) Reiterated at Market Outperform by Citizens
- Neutron Holdings (LIME) PT Lowered to $33 at Citizens - 'Quarter Appears Less Positive than Hoped'
- Citi reiterates Buy rating on Instacart amid reported sale talks
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
